These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29688304)

  • 1. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST).
    Hindricks G; Varma N; Kacet S; Lewalter T; Søgaard P; Guédon-Moreau L; Proff J; Gerds TA; Anker SD; Torp-Pedersen C
    Eur Heart J; 2017 Jun; 38(22):1749-1755. PubMed ID: 29688304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial.
    Guédon-Moreau L; Lacroix D; Sadoul N; Clémenty J; Kouakam C; Hermida JS; Aliot E; Boursier M; Bizeau O; Kacet S;
    Eur Heart J; 2013 Feb; 34(8):605-14. PubMed ID: 23242192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial.
    Hindricks G; Elsner C; Piorkowski C; Taborsky M; Geller JC; Schumacher B; Bytesnik J; Kottkamp H
    Eur Heart J; 2014 Jan; 35(2):98-105. PubMed ID: 23868932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic remote monitoring utilizing daily transmissions: transmission reliability and implantable cardioverter defibrillator battery longevity in the TRUST trial.
    Varma N; Love CJ; Schweikert R; Moll P; Michalski J; Epstein AE;
    Europace; 2018 Apr; 20(4):622-628. PubMed ID: 29016878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote monitoring of patients with implantable cardioverter-defibrillators: can results from large clinical trials be transposed to clinical practice?
    Morichau-Beauchant T; Boulé S; Guédon-Moreau L; Finat L; Botcherby EJ; Périer MC; Salleron J; Guibout C; Marquié C; Klug D; Kouakam C; Wissocque L; Brigadeau F; Lacroix D; Kacet S
    Arch Cardiovasc Dis; 2014 Dec; 107(12):664-71. PubMed ID: 25241223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
    Varma N; Epstein AE; Irimpen A; Schweikert R; Love C;
    Circulation; 2010 Jul; 122(4):325-32. PubMed ID: 20625110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial.
    Boriani G; Da Costa A; Quesada A; Ricci RP; Favale S; Boscolo G; Clementy N; Amori V; Mangoni di S Stefano L; Burri H;
    Eur J Heart Fail; 2017 Mar; 19(3):416-425. PubMed ID: 27568392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote monitoring to Improve long-term prognosis in heart failure patients with implantable cardioverter-defibrillators.
    Ono M; Varma N
    Expert Rev Med Devices; 2017 May; 14(5):335-342. PubMed ID: 28299956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote monitoring and clinical outcomes: details on information flow and workflow in the IN-TIME study.
    Husser D; Christoph Geller J; Taborsky M; Schomburg R; Bode F; Nielsen JC; Stellbrink C; Meincke C; Hjortshøj SP; Schrader J; Lewalter T; Hindricks G
    Eur Heart J Qual Care Clin Outcomes; 2019 Apr; 5(2):136-144. PubMed ID: 30016396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manpower and outpatient clinic workload for remote monitoring of patients with cardiac implantable electronic devices: data from the HomeGuide Registry.
    Ricci RP; Morichelli L; D'Onofrio A; Calò L; Vaccari D; Zanotto G; Curnis A; Buja G; Rovai N; Gargaro A
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1216-23. PubMed ID: 24964380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.
    Sun WP; Li CL; Guo JC; Zhang LX; Liu R; Zhang HB; Zhang L
    Heart Fail Rev; 2016 Jul; 21(4):447-53. PubMed ID: 27043219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations.
    Varma N; Michalski J; Stambler B; Pavri BB;
    Eur Heart J; 2014 May; 35(20):1345-52. PubMed ID: 24595864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis.
    Betts TR; Sadarmin PP; Tomlinson DR; Rajappan K; Wong KC; de Bono JP; Bashir Y
    Europace; 2013 Jun; 15(6):813-9. PubMed ID: 23365069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study.
    De Simone A; Leoni L; Luzi M; Amellone C; Stabile G; La Rocca V; Capucci A; D'onofrio A; Ammendola E; Accardi F; Valsecchi S; Buja G
    Europace; 2015 Aug; 17(8):1267-75. PubMed ID: 25842271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.
    Varma N; Michalski J; Epstein AE; Schweikert R
    Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):428-36. PubMed ID: 20716717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of remote monitoring on long-term cardiovascular outcomes after cardioverter-defibrillator implantation.
    Portugal G; Cunha P; Valente B; Feliciano J; Lousinha A; Alves S; Braz M; Pimenta R; Delgado AS; Oliveira M; Ferreira RC
    Int J Cardiol; 2016 Nov; 222():764-768. PubMed ID: 27521554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes.
    Parthiban N; Esterman A; Mahajan R; Twomey DJ; Pathak RK; Lau DH; Roberts-Thomson KC; Young GD; Sanders P; Ganesan AN
    J Am Coll Cardiol; 2015 Jun; 65(24):2591-2600. PubMed ID: 25983009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.